The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 594-601

  Lam, Paula Y P ^a,c   Sublett, Jack E ^a   Hollenbach, Andrew D ^a   Roussel, Martine F ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Department of Tumor Cell Biology ^*  (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 2; GENE MUTATION; GROWTH REGULATION; LUNG ALVEOLUS CELL CARCINOMA; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; RHABDOMYOSARCOMA; TRANSCRIPTION REGULATION;

EID: 0032906216     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.594     Document Type: Article

References (35)

1. Ausubel, F. M., R. Brent, K. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1996. Current protocols in molecular biology. John Wiley & Sons, Boston, Mass.
2. Balling, R., U. Deutsch, and P. Gruss. 1988. Undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax1. Cell 55:531-535.
3. Bennicelli, J. L., W. J. Fredericks, R. B. Wilson, F. J. Rauscher III, and F. G. Barr. 1995. Wild type Pax3 protein and the Pax3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains. Oncogene 11:119-130.
4. Bennicelli, J. L., R. H. Edwards, and F. G. Barr. 1996. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 93:5455-5459.
5. Braum, R. J., D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
6. Brennan, R. G. 1993. The winged-helix DNA-binding motif: another helix-turn-helix takeoff. Cell 74:773-776.
7. Chalepakis, G., R. Fritsch, H. R. Fickenscher, U. Deutsch, M. Goulding, and P. Gruss. 1991. The molecular basis of the undulated/Pax1 mutation. Cell 66:873-884.
8. Chang, C.-P., L. Brocchieri, W.-F. Shen, C. Largman, and M. L. Cleary. 1996. Pbx modulation of Hox homeodomain amino-terminal arms establishes different DNA-binding specificities across the Hox locus. Mol. Cell. Biol. 16:1734-1745.
9. Chang, C.-P., I. de Vivo, and M. L. Cleary. 1997. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis. Mol. Cell. Biol. 17:81-88.
10. Davis, R. J., and F. G. Barr. 1997. Fusion genes resulting from alternative chromosomal translocations are overexpressed by gene-specific mechanisms in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 94:8047-8051.
11. Dingwall, C., and R. Laskey. 1992. The nuclear membrane. Science 258:942-947.
12. Epstein, J. A., P. Lam, L. Jepeal, R. L. Maas, and D. N. Shapiro. 1995. Pax3 inhibits myogenic differentiation of cultured myoblast cells. J. Biol. Chem. 270:11719-11722.
13. Fredericks, W. J., N. Galili, S. Mukhopadhyay, G. Rovera, J. Bennicelli, F. G. Barr, and F. J. I. Rauscher III. 1995. The Pax3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than Pax3. Mol. Cell. Biol. 15:1522-1535.
14. Galili, N., R. J. Davis, W. J. Fredericks, S. Mukhopadhyay, F. J. Rauscher III, B. S. Emanuel, G. Rovera, and F. G. Barr. 1993. Fusion of a forkhead domain gene to Pax3 in the solid tumor alveolar rhabdomyosarcoma. Nature 5:230-235.
15. Goulding, M. D., G. Chalepakis, U. Deutsch, J. R. Erselius, and P. Gruss. 1991. Pax3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10:1135-1147.
16. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
17. Guichet, A., J. W. R. Copeland, M. Erdelyi, D. Hlousek, P. Zavorsky, J. Ho, S. Brown, A. Percival-Smith, H. M. Krause, and A. Ephrussi. 1997. The nuclear receptor homologue Ftz-F1 and the homeodomain protein Ftz are mutually dependent cofactors. Nature 385:552-555.
18. Ho, S., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
19. Horton, R. M., H. D. Hunt, S. N. Ho, J. K. Pullen, and L. R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68.
20. Hoth, C. F., A. Milunsky, N. Lipsky, R. Sheffer, S. K. Clarren, and C. T. Baldwin. 1993. Mutations in the paired domain of the human Pax3 gene cause Klein-Waardenburg Syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52:455-462.
21. Kamps, M. P., C. Murre, X.-H. Sun, and D. Baltimore. 1990. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60:547-555.
22. Maulbecker, C. C., and P. Gruss. 1993. The oncogenic potential of Pax genes. EMBO J. 12:2361-2367.
23. Monica, K., D. P. LeBrun, D. A. Dedera, R. Brown, and M. L. Cleary. 1994. Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol. Cell. Biol. 14:8304-8314.
24. Muller, A. J., J. C. Young, A.-M. Pendergast, M. Pondel, N. R. Landau, D. R. Littman, and O. N. Witte. 1991. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive leukemias. Mol. Cell. Biol. 11:1785-1792.
25. Newberry, E. P., T. Latifi, J. T., Battaile, and D. A. Towler. 1997. Structure-function analysis of Msx2-mediated transcriptional suppression. Biochemistry 36:10451-10462.
26. Nourse, J., J. D. Mellentin, N. Galili, J. Wilkinson, E. Stanbridge, S. D. Smith, and M. L. Cleary. 1990. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60:535-545.
27. Pappo, A. S., D. N. Shapiro, W. M. Crist, and H. M. Maurer. 1995. Biology and therapy of pediatric rhabdomyosarcoma. J. Clin. Oncol. 13:2123-2139.
28. Babbitts, T. H. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
29. Roussel, M. F., A. M. Theodoras, M. Pagano, and C. J. Sherr. 1995. Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl. Acad. Sci. USA 92:6837-6841.
30. Scheidler, S., W. J. Fredericks, F. J. Rauscher III, F. G. Barr, and P. K. Vogt. 1996. The hybrid Pax3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl. Acad. Sci. USA 93:9805-9809.
31. Shapiro, D. N., J. E. Sublett, B. Li, J. R. Downing, and C. W. Naeve. 1993. Fusion of Pax3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res. 53:5108-5112.
32. Strachan, T., and A. P. Read. 1994. Pax genes. Curr. Opin. Gen. Dev. 4:427-438.
33. Stuart, E. T., C. Kioussi, and P. Gruss. 1993. Mammalian Pax genes. Annu. Rev. Genet. 27:219-236.
34. Wilson, D. S., B. Guenther, C. Desplan, and J. Kuriyan. 1995. High resolution crystal structure of a paired (Pax) class cooperative homodomain dimer on DNA. Cell 82:709-719.
35. Xu, W., M. A. Rold, S. Jun, C. Desplan, and C. O. Pabo. 1995. Crystal structure of a paired domain-DNA complex at 2.5 angstrom resolution reveals structural basis of Pax developmental mutations. Cell 80:639-650.